NY-UPTIME-INSTITUTE
20.9.2022 12:03:37 CEST | Business Wire | Press release
Uptime Institute today announced the release of its 12th Annual Global Data Center Survey. The findings show an industry that is growing, dynamic and increasingly resilient, but still working to address increasing pressure for sustainability progress and reporting, continuing staffing shortages, supply chain delays, costly outages and other complex challenges.
“The global digital infrastructure sector continues to enjoy strong growth and expansion, despite the many obstacles operators are facing today,” said Andy Lawrence, executive director of research, Uptime Institute Intelligence. “We’ve seen the industry invest in increased resiliency and reliability, but there’s still work to be done when it comes to improving efficiency, environmental sustainability, outage prevention, staffing pipelines and more.”
Uptime’s annual Global Data Center Survey is the largest and most comprehensive in the digital infrastructure industry. It provides detailed insights into the digital critical infrastructure landscape and a sense of its future trajectory. Key findings from the 2022 report include:
- Many data center operators are unprepared for mounting sustainability requirements and regulations – Most respondents say they report on overall data center power use and PUE, but many still are not tracking critical environmental metrics. Although 63% of operators believe authorities in their region will require them to publicly report environmental data in the next five years, just 37% collect and report carbon emissions data (a slight increase over 33% in 2021) and only 39% currently report their water use (a 12% drop compared to 2021). New laws, standards, and requirements will force operators to address these gaps and establish more stringent sustainability tracking and reporting practices in the coming years.
- PUE progress is in stasis for now and future efficiency gains must focus on IT power – The average annual power usage effectiveness (PUE) reported in 2022 was 1.55. This represents a slight improvement over the 2021 average of 1.57, which is consistent with the trend of marginal PUE gains Uptime has observed annually since 2014. Going forward, achieving substantial data center efficiency improvements will require a new focus on IT efficiency, along with metrics to track and report progress.
- More operators are investing to bolster data center resiliency – Data center owners and operators are making significant investments in the resiliency of their physical infrastructure, with about 40% of respondents reporting increased redundancy levels at their primary data centers in the past three to five years. Power and cooling systems have received similar attention, with a third of operators upgrading either or both.
- Outages are becoming more expensive and are still far too frequent – The share of all outages costing operators over $1 million has reached 25%, a significant increase from 15% in 2021. In 2022, 60% of operators reported experiencing an outage (regardless of severity) in the past three years — down from 69% in 2021 and 78% in 2020. Although the data indicates a trend toward improved outage rates, the frequency of outages is still much too high and with more than two-thirds now costing operators upwards of $100,000, the consequences are getting worse.
- Operators’ confidence in public cloud is on the rise, despite ongoing outage risks – As the perception of improved visibility into cloud operational resiliency grows, organizations are more likely to trust the cloud for mission-critical workloads. In 2022, just 63% of operators are not placing mission-critical workloads into a public cloud, a substantial drop from almost 75% in 2019. That trust might be misplaced, given that more than one-third of respondents report that public cloud availability zone outages (which are relativity common) would cause significant performance issues.
- Data center equipment vendors optimistic despite demand pressures and lingering supply chain problems – Three-quarters of vendors project year-over-year revenue growth in 2022 despite reporting dampened revenues due to persistent COVID-induced supply chain issues. Nearly half of respondents involved with data center construction have suffered significant delays (or other events) in their supply chains, while one-third have experienced moderate issues.
- Problems attracting and retaining qualified staff are worsening – Over half (53%) of data center operators report difficulty finding qualified employees in 2022 — up from 47% in 2021 and 38% in 2018. And 42% of respondents report issues with staff being hired away (in most cases to data center competitors) – a massive increase over just 17% in 2018, which demonstrates the growing challenge of employee retention throughout the sector.
Learn More: Uptime’s 2022 Global Data Center Survey also includes findings on industry attitudes toward nuclear energy, server refresh rates, rack density trends and much more. Download the complete report here, and register for the webinar covering its key trends and takeaways on September 28th at 11:00 a.m. ET.
About the Survey: Uptime conducts its annual Global Data Center Survey online and by email. This year’s study took place in H1 2022, and includes responses from approximately 800 data center owners and operators responsible for managing infrastructure at the world’s largest IT organizations. It also includes insights from 700 data center suppliers, designers, and advisors worldwide.
About Uptime Institute
Uptime Institute is the Global Digital Infrastructure Authority. For over 25 years, the company has established industry-leading benchmarks for data center performance, resilience, sustainability, and efficiency, which provide customers assurance that their digital infrastructure can perform across a wide array of operating conditions at a level consistent with their business needs. Uptime’s Tier Standard is the IT industry’s most trusted and adopted global standard for the design, construction, and operation of data centers – the backbone of the digital economy. With its Tier Standard and Certifications, Management & Operations reviews, SCIRA-FSI financial sector risk assessment, broad range of additional risk and performance assessments, Intelligence research services, and accredited training courses completed by over 10,000 data center professionals, Uptime has helped thousands of companies in over 100 countries to optimize critical IT assets while managing costs, resources, and efficiency.
Uptime Institute is headquartered in New York, NY, with offices in Seattle, London, Sao Paulo, Dubai, Singapore, and Taipei. For more information, please visit www.uptimeinstitute.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220920005231/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 202612.6.2026 12:00:00 CEST | Press release
Tacabrutideg (BGB-16673, BTK degrader) showed durable responses in heavily pretreated R/R CLL and BTK inhibitor–naïve patients, signaling potential for earlier lines of treatmentBRUKINSA plus sonrotoclax (ZS) delivered deep, durable responses and high uMRD rates across TN CLL and R/R MCL and CLL, reinforcing its potential as an all-oral, fixed-duration treatment BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with early activity also seen in BTK inhibitor–naïve patients. These data are complemented by results from the all-oral combination of BRUKINSA® (zanubru
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
